CHAPTER 1 INTRODUCTION
1.1. Market Definition
1.2. Executive Summary
1.3. The Scope of the Study
CHAPTER 2 RESEARCH METHODOLOGY
2.1. Secondary Research
2.2. Primary Research
2.3. Analytic Tools and Model
2.4. Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5. Expert Validation
2.6. Study Timeline
CHAPTER 3 MARKET ANALYSIS
3.1. Industry Value Chain Analysis
3.2. Porter's Five Force Analysis
3.2.1. Bargaining Power of Buyers
3.2.2. Bargaining Power of Suppliers
3.2.3. Threats of Substitutes
3.2.4. Threats of New Entrants
3.2.5. Degree of Competition
3.3. PESTLE Analysis
3.3.1. Political
3.3.2. Economical
3.3.3. Social
3.3.4. Technological
3.3.5. Legal
3.3.6. Environmental
3.4. SWOT Analysis
3.4.1. Strengths
3.4.2. Weakness
3.4.3. Opportunities
3.4.4. Threats
3.5. Y-O-Y Analysis
CHAPTER 4 MARKET DYNAMICS
4.1. Market Drivers
4.1.1. Increasing government funding & healthcare expenditure
4.1.2. Adoption of In-House sample storage in hospitals & labs
4.1.3. Growing investments in biobanks and personalised medicine
4.1.4. Increasing adoption of advanced technologies such as stem cell therapies,regenerative
medicines, and others
4.2. Market Restraints & Challenges
4.2.1. Expensive cost of instruments and maintenance
4.2.2. Tissues injuries during preservation and melting
4.3. Market Opportunities
4.3.1. Government initiatives to enhance bio-banking and freezing standards
4.3.2. Emerging economies
CHAPTER 5 GLOBAL BIOPRESERVATION MARKET – BY PRODUCT
5.1. Equipment
5.1.1. Freezers
5.1.2. Refrigerators
5.1.3. Consumables
5.1.3.1. Vials
5.1.3.2. Straws
5.1.3.3. Bags
5.1.3.4. Microtiter Plates
5.1.4. Liquid Nitrogen
5.1.5. Incubators
5.1.6. Centrifuges
5.1.7. Alarms & Monitoring Systems
5.1.8. Accessories
5.1.9. Others
5.2. Media
5.2.1. Pre-formulated
5.2.2. Home-brew
5.2.3. Others
5.3. LIMS (Laboratory Information Management System)
CHAPTER 6 GLOBAL BIOPRESERVATION MARKET – BY BIOSPECIMEN
6.1. Human Tissue Samples
6.2. Organs
6.3. Stem cells
6.4. Others
CHAPTER 7 GLOBAL BIOPRESERVATION MARKET – BY APPLICATION
7.1. Drug Discovery
7.2. Therapeutic Applications
7.2.1. Cell Therapy
7.2.2. Gene Therapy
7.2.3. Others
7.3. Biobanking
7.3.1. Human Eggs
7.3.2. Human Sperm
7.3.3. Veterinary IVF
7.5. Clinical Trials
7.6. Others
CHAPTER 8 GLOBAL BIOPRESERVATION MARKET – BY END USER
8.1. Biobanks
8.2. Gene Banks
8.3. Hospitals
8.4. Others
CHAPTER 9 GLOBAL BIOPRESERVATION MARKET - BY GEOGRAPHY
9.1. Introduction
9.2. North America
9.2.1. U.S.
9.2.2. Canada
9.2.3. Mexico
9.2.4. Costa Rica
9.3. South America
9.3.1. Brazil
9.3.2. Argentina
9.3.3. Chile
9.3.4. Columbia
9.3.5. Others
9.4. Europe
9.4.1. U.K.
9.4.2. Germany
9.4.3. France
9.4.4. Italy
9.4.5. Spain
9.4.6. Russia
9.4.7. Netherlands
9.4.8. Switzerland
9.4.9. Poland
9.4.10. Others
9.5. APAC
9.5.1. China
9.5.2. Japan
9.5.3. India
9.5.4. South Korea
9.5.5. Australia & New Zealand
9.5.6. Malaysia
9.5.7. Singapore
9.5.8. Others
9.6. Middle East & Africa
9.6.1. UAE
9.6.2. Saudi Arabia
9.6.3. Iran
9.6.4. Iraq
9.6.5. Qatar
9.6.6. South Africa
9.6.7. Algeria
9.6.8. Morocco
9.6.9. Nigeria
9.6.10. Egypt
9.6.11. Others
CHAPTER 10 GLOBAL BIOPRESERVATION MARKET - COMPANY PROFILES
10.1. BioLife Solutions Inc.
10.2. Thermo Fisher Scientific Inc.
10.3. VWR International LLC
10.4. BioCision LLC
10.5. Biomartica Inc.
10.6. Panasonic Corporation
10.7. QIAGEN
10.8. LABVANTAGE Solutions Inc.
10.9. Cesca Therapeutics Inc.
10.10. Lifeline Scientific Inc.
10.11. Princeton CryoTech Inc.
10.12. Sigma-Aldrich Corporation
10.13. Custom Biogenic Systems Inc.
10.14. Core Dynamics Ltd.
10.15. So-Low Environmental Equipment Co., Inc.
CHAPTER 11 GLOBAL BIOPRESERVATION MARKET - COMPETITIVE
LANDSCAPE
11.1. Market Share Analysis
11.2. Strategies adopted by top companies
11.3. Mergers, Acquisitions, Collaborations & Agreements
CHAPTER 12 MARKET INSIGHTS
12.1. Industry Experts Insights
12.2. Analysts Opinions
12.3. Investment Opportunities
CHAPTER 13 APPENDIX
13.1. List of Tables
13.2. List of Figures
